MORGAN STANLEY PLC/CALL/CENCORA/310/0.1/20.12.24

MORGAN STANLEY PLC/CALL/CENCORA/310/0.1/20.12.24 Stock

DE000MG0FS75

Market Closed - Börse Stuttgart 14:35:24 2024-06-06 EDT
0.098 ^EUR	+12.64%

Current month	+28.95%
1 month	-28.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart CENCORA, INC.

Chart MORGAN STANLEY PLC/CALL/CENCORA/310/0.1/20.12.24

Latest news about CENCORA, INC.

Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing	06-03	MT
Cencora, Inc. Revises Earnings Guidance for the Fiscal Year 2024	05-30	CI
Transcript : Cencora, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 09:20 AM	05-30
Baird Adjusts Price Target on Cencora to $280 From $277	05-29	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-06	0.098	+12.64%
24-06-05	0.087	0.00%
24-06-04	0.087	0.00%
24-06-03	0.087	+14.47%
24-05-31	0.076	+15.15%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 02:35 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	CENCORA, INC.
Issuer	Morgan Stanley
WKN	MG0FS7
ISIN	DE000MG0FS75
Date issued	2024-03-20
Strike	310 $
Maturity	2024-12-20 (197 Days)
Parity	10 : 1
Emission price	0.17 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.53 €
Lowest since issue	0.023 €
Delta	0.08x
Omega	14.54
Premium	31.58x
Gearing	188.03x
Moneyness	0.7631
Difference Strike	73.33 $
Difference Strike %	+23.65%
Spread	0.027 €
Spread %	20.93%
Theoretical value	0.1155
Implied Volatility	22.16 %
Total Loss Probability	94.35 %
Intrinsic value	0.000000
Present value	0.1155
Break even	311.26 €
Theta	-0.01x
Vega	0.02x
Rho	0.01x

Company Profile

Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).

Sector

More about the company

Ratings for Cencora, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Cencora, Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

236.7 USD

Average target price

255.3 USD

Spread / Average Target

+7.89%

Consensus